Endocannabinoids regulate interneuron migration and morphogenesis by transactivating the TrkB receptor.
暂无分享,去创建一个
G. Schulte | K. Mackie | T. Harkany | Y. Hurd | P. Ernfors | G. Paratcha | P. Berghuis | M. Dobszay | Kyle M. Sousa | F. Ledda | S. Spano | Xinyu Wang | Paul Berghuis
[1] Prahlad T. Ram,et al. The Gαo/i-coupled Cannabinoid Receptor-mediated Neurite Outgrowth Involves Rap Regulation of Src and Stat3* , 2005, Journal of Biological Chemistry.
[2] Y. Ben-Ari,et al. Altering cannabinoid signaling during development disrupts neuronal activity. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[3] A. Finazzi-Agro’,et al. Lipid Rafts Control Signaling of Type-1 Cannabinoid Receptors in Neuronal Cells , 2005, Journal of Biological Chemistry.
[4] S. Hestrin,et al. Electrical Coupling among Irregular-Spiking GABAergic Interneurons Expressing Cannabinoid Receptors , 2004, The Journal of Neuroscience.
[5] G. Schulte,et al. Brain‐derived neurotrophic factor controls functional differentiation and microcircuit formation of selectively isolated fast‐spiking GABAergic interneurons , 2004, The European journal of neuroscience.
[6] F. Lee,et al. Transactivation of Trk Neurotrophin Receptors by G-Protein-Coupled Receptor Ligands Occurs on Intracellular Membranes , 2004, The Journal of Neuroscience.
[7] D. Fortin,et al. Endocannabinoid signalling selectively targets perisomatic inhibitory inputs to pyramidal neurones in juvenile mouse neocortex , 2004, The Journal of physiology.
[8] A. Ullrich,et al. Cannabinoids Induce Cancer Cell Proliferation via Tumor Necrosis Factor α-Converting Enzyme (TACE/ADAM17)-Mediated Transactivation of the Epidermal Growth Factor Receptor , 2004, Cancer Research.
[9] S. Pyne,et al. Receptor tyrosine kinase-GPCR signal complexes. , 2003, Biochemical Society transactions.
[10] Gareth Williams,et al. Cloning of the first sn1-DAG lipases points to the spatial and temporal regulation of endocannabinoid signaling in the brain , 2003, The Journal of cell biology.
[11] Elaine Fuchs,et al. Differential regulation of midbrain dopaminergic neuron development by Wnt-1, Wnt-3a, and Wnt-5a , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[12] T. Freund,et al. Postnatal development and migration of cholecystokinin-immunoreactive interneurons in rat hippocampus , 2003, Neuroscience.
[13] Y. Morozov,et al. Post‐natal development of type 1 cannabinoid receptor immunoreactivity in the rat hippocampus , 2003, The European journal of neuroscience.
[14] T. Freund,et al. Role of endogenous cannabinoids in synaptic signaling. , 2003, Physiological reviews.
[15] G. Paratcha,et al. The Neural Cell Adhesion Molecule NCAM Is an Alternative Signaling Receptor for GDNF Family Ligands , 2003, Cell.
[16] S. Anderson,et al. Cortical interneuron fate determination: diverse sources for distinct subtypes? , 2003, Cerebral cortex.
[17] Y. Hurd,et al. Preferential limbic expression of the cannabinoid receptor mRNA in the human fetal brain , 2003, Neuroscience.
[18] Á. Pazos,et al. Ontogenetic development of cannabinoid receptor expression and signal transduction functionality in the human brain , 2003, The European journal of neuroscience.
[19] L. Ferraro,et al. Prenatal exposure to a cannabinoid agonist produces memory deficits linked to dysfunction in hippocampal long-term potentiation and glutamate release , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[20] F. Walsh,et al. The FGF receptor uses the endocannabinoid signaling system to couple to an axonal growth response , 2003, The Journal of cell biology.
[21] K. Mackie,et al. Nonpsychotropic Cannabinoid Receptors Regulate Microglial Cell Migration , 2003, The Journal of Neuroscience.
[22] I. Galve-Roperh,et al. The Endocannabinoid Anandamide Inhibits Neuronal Progenitor Cell Differentiation through Attenuation of the Rap1/B-Raf/ERK Pathway* , 2002, The Journal of Biological Chemistry.
[23] H. Jahnsen,et al. Pilocarpine-induced seizure-like activity with increased BNDF and neuropeptide Y expression in organotypic hippocampal slice cultures , 2002, Brain Research.
[24] R. Nicoll,et al. Endocannabinoid Signaling in the Brain , 2002, Science.
[25] F. Lee,et al. Activation of Trk Neurotrophin Receptor Signaling by Pituitary Adenylate Cyclase-activating Polypeptides* , 2002, The Journal of Biological Chemistry.
[26] A. Patapoutian,et al. Trk receptors: mediators of neurotrophin action , 2001, Current Opinion in Neurobiology.
[27] S. Thayer,et al. Cannabinoids Inhibit the Formation of New Synapses between Hippocampal Neurons in Culture , 2001, The Journal of Neuroscience.
[28] G. Marsicano,et al. Expression of the cannabinoid receptor CB1 in distinct neuronal subpopulations in the adult mouse forebrain , 1999, The European journal of neuroscience.
[29] Ken Mackie,et al. Presynaptically Located CB1 Cannabinoid Receptors Regulate GABA Release from Axon Terminals of Specific Hippocampal Interneurons , 1999, The Journal of Neuroscience.
[30] P. Fried,et al. Differential effects on cognitive functioning in 13- to 16-year-olds prenatally exposed to cigarettes and marihuana. , 1998, Neurotoxicology and teratology.
[31] R. McKay,et al. Neurotrophins Stimulate Chemotaxis of Embryonic Cortical Neurons , 1997, The European journal of neuroscience.
[32] Leyuan Shi,et al. Interneuron migration from basal forebrain to neocortex: dependence on Dlx genes. , 1997, Science.
[33] H. Thoenen,et al. GABAergic Stimulation Regulates the Phenotype of Hippocampal Interneurons through the Regulation of Brain-Derived Neurotrophic Factor , 1996, Neuron.
[34] A. Ullrich,et al. Role of transactivation of the EGF receptor in signalling by G-protein-coupled receptors , 1996, Nature.
[35] P. Lönnerberg,et al. Role of variable beta-hairpin loop in determining biological specificities in neurotrophin family. , 1994, The Journal of biological chemistry.
[36] D. Sternberg,et al. K-252a inhibits nerve growth factor-induced trk proto-oncogene tyrosine phosphorylation and kinase activity. , 1992, The Journal of biological chemistry.
[37] Franjo Grotenhermen,et al. Pharmacokinetics and Pharmacodynamics of Cannabinoids , 2003, Clinical pharmacokinetics.